Los Angeles Capital Management LLC Biomarin Pharmaceutical Inc Transaction History

Los Angeles Capital Management LLC

$27.9 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$76.22 - $98.51 $526,756 - $680,802	6,911 New	6,911 $666,000
Q2 2023 Aug 03, 2023	SELL	$86.68 - $100.3 $1.18 Million - $1.36 Million	-13,583 Reduced 17.94%	62,126 $5.39 Million
Q1 2023 May 04, 2023	SELL	$87.74 - $117.27 $106,340 - $142,131	-1,212 Reduced 1.58%	75,709 $7.36 Million
Q4 2022 Feb 06, 2023	BUY	$80.93 - $108.63 $6.23 Million - $8.36 Million	76,921 New	76,921 $7.96 Million
Q3 2020 Nov 02, 2020	SELL	$71.87 - $131.03 $975,275 - $1.78 Million	-13,570 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$79.55 - $124.22 $206,989 - $323,220	2,602 Added 23.72%	13,570 $1.67 Million
Q1 2020 May 04, 2020	SELL	$71.37 - $96.85 $284,052 - $385,463	-3,980 Reduced 26.63%	10,968 $927,000
Q4 2019 Feb 07, 2020	BUY	$64.27 - $86.37 $960,707 - $1.29 Million	14,948 New	14,948 $1.26 Million
Q2 2019 Jul 29, 2019	SELL	$80.35 - $93.9 $1.02 Million - $1.19 Million	-12,688 Closed	0 $0
Q1 2019 Apr 25, 2019	SELL	$84.2 - $98.62 $64,834 - $75,937	-770 Reduced 5.72%	12,688 $1.13 Million
Q4 2018 Feb 11, 2019	SELL	$80.14 - $106.07 $1.39 Million - $1.84 Million	-17,360 Reduced 56.33%	13,458 $1.15 Million
Q3 2018 Nov 05, 2018	BUY	$93.92 - $105.72 $1.27 Million - $1.42 Million	13,470 Added 77.65%	30,818 $2.99 Million
Q2 2018 Jul 31, 2018	BUY	$76.01 - $99.03 $921,241 - $1.2 Million	12,120 Added 231.83%	17,348 $1.63 Million
Q1 2018 Apr 27, 2018	SELL	$77.67 - $92.63 $168,543 - $201,007	-2,170 Reduced 29.33%	5,228 $424,000
Q4 2017 Feb 05, 2018	SELL	$80.76 - $95.13 $5.34 Million - $6.29 Million	-66,153 Reduced 89.94%	7,398 $660,000
Q3 2017 Nov 06, 2017	BUY	$80.6 - $94.95 $3.25 Million - $3.83 Million	40,357 Added 121.58%	73,551 $6.85 Million
Q2 2017 Aug 09, 2017	BUY	N/A	33,194	33,194 $3.02 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account